Using cutoff values of MYC (40%) and BCL2 (50%) positive tumor cells, twenty-eight (32.2%) were diagnosed as double-expressor lymphoma (DEL), thirty-two (36.8%) as non-DEL and twenty-seven (31%) as unknown. This evidence concerns the gene BCL2 and neoplasm.